ID   DXR_ECOLI               Reviewed;         398 AA.
AC   P45568; P77209; Q8KMY5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   15-MAR-2017, entry version 147.
DE   RecName: Full=1-deoxy-D-xylulose 5-phosphate reductoisomerase;
DE            Short=DXP reductoisomerase;
DE            EC=1.1.1.267;
DE   AltName: Full=1-deoxyxylulose-5-phosphate reductoisomerase;
DE   AltName: Full=2-C-methyl-D-erythritol 4-phosphate synthase;
GN   Name=dxr; Synonyms=ispC, yaeM; OrderedLocusNames=b0173, JW0168;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHARACTERIZATION.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9707569; DOI=10.1073/pnas.95.17.9879;
RA   Takahashi S., Kuzuyama T., Watanabe H., Seto H.;
RT   "A 1-deoxy-D-xylulose 5-phosphate reductoisomerase catalyzing the
RT   formation of 2-C-methyl-D-erythritol 4-phosphate in an alternative
RT   nonmevalonate pathway for terpenoid biosynthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:9879-9884(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RA   Takemoto K., Mori H., Murayama N., Kataoka K., Yano M., Itoh T.,
RA   Yamamoto Y., Inokuchi H., Miki T., Hatada E., Fukuda R., Ichihara S.,
RA   Mizuno T., Makino K., Nakata A., Yura T., Sampei G., Mizobuchi K.;
RT   "Systematic sequencing of the Escherichia coli genome: analysis of the
RT   4.0 - 6.0 min (189,987 - 281,416bp) region.";
RL   Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RA   Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M.,
RA   Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D.,
RA   Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.;
RT   "Sequence of minutes 4-25 of Escherichia coli.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND SEQUENCE REVISION
RP   TO 277-284.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-204.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8202364; DOI=10.1093/nar/22.9.1637;
RA   Fujita N., Mori H., Yura T., Ishihama A.;
RT   "Systematic sequencing of the Escherichia coli genome: analysis of the
RT   2.4-4.1 min (110,917-193,643 bp) region.";
RL   Nucleic Acids Res. 22:1637-1639(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-49.
RX   PubMed=1447125; DOI=10.1128/jb.174.23.7517-7526.1992;
RA   Yamanaka K., Ogura T., Niki H., Hiraga S.;
RT   "Identification and characterization of the smbA gene, a suppressor of
RT   the mukB null mutant of Escherichia coli.";
RL   J. Bacteriol. 174:7517-7526(1992).
RN   [8]
RP   IDENTIFICATION.
RX   PubMed=7567469; DOI=10.1093/nar/23.17.3554;
RA   Borodovsky M., McIninch J., Koonin E.V., Rudd K.E., Medigue C.,
RA   Danchin A.;
RT   "Detection of new genes in a bacterial genome using Markov models for
RT   three gene classes.";
RL   Nucleic Acids Res. 23:3554-3562(1995).
RN   [9]
RP   CHARACTERIZATION.
RX   PubMed=10631325; DOI=10.1016/S0014-5793(99)01743-3;
RA   Radykewicz T., Rohdich F., Wungsintaweekul J., Herz S., Kis K.,
RA   Eisenreich W., Bacher A., Zenk M.H., Arigoni D.;
RT   "Biosynthesis of terpenoids: 1-deoxy-D-xylulose-5-phosphate
RT   reductoisomerase from Escherichia coli is a class B dehydrogenase.";
RL   FEBS Lett. 465:157-160(2000).
RN   [10]
RP   CHARACTERIZATION, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF
RP   GLY-14; HIS-153; HIS-209; GLU-231 AND HIS-257.
RX   PubMed=10787409; DOI=10.1074/jbc.M001820200;
RA   Kuzuyama T., Takahashi S., Takagi M., Seto H.;
RT   "Characterization of 1-deoxy-D-xylulose 5-phosphate reductoisomerase,
RT   an enzyme involved in isopentenyl diphosphate biosynthesis, and
RT   identification of its catalytic amino acid residues.";
RL   J. Biol. Chem. 275:19928-19932(2000).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 2-398 IN COMPLEX WITH NADPH.
RX   PubMed=11872159; DOI=10.1093/oxfordjournals.jbchem.a003105;
RA   Yajima S., Nonaka T., Kuzuyama T., Seto H., Ohsawa K.;
RT   "Crystal structure of 1-deoxy-D-xylulose 5-phosphate reductoisomerase
RT   complexed with cofactors: implications of a flexible loop movement
RT   upon substrate binding.";
RL   J. Biochem. 131:313-317(2002).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS), AND SUBUNIT.
RX   PubMed=11741911; DOI=10.1074/jbc.M109500200;
RA   Reuter K., Sanderbrand S., Jomaa H., Wiesner J., Steinbrecher I.,
RA   Beck E., Hintz M., Klebe G., Stubbs M.T.;
RT   "Crystal structure of 1-deoxy-D-xylulose-5-phosphate reductoisomerase,
RT   a crucial enzyme in the non-mevalonate pathway of isoprenoid
RT   biosynthesis.";
RL   J. Biol. Chem. 277:5378-5384(2002).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH MANGANESE IONS
RP   AND FOSMIDOMYCIN, AND SUBUNIT.
RX   PubMed=12621040; DOI=10.1074/jbc.M300993200;
RA   Steinbacher S., Kaiser J., Eisenreich W., Huber R., Bacher A.,
RA   Rohdich F.;
RT   "Structural basis of fosmidomycin action revealed by the complex with
RT   2-C-methyl-D-erythritol 4-phosphate synthase (IspC). Implications for
RT   the catalytic mechanism and anti-malaria drug development.";
RL   J. Biol. Chem. 278:18401-18407(2003).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 2-398 IN COMPLEX WITH
RP   SUBSTRATE ANALOG.
RX   PubMed=15339150; DOI=10.1021/ja040126m;
RA   Yajima S., Hara K., Sanders J.M., Yin F., Ohsawa K., Wiesner J.,
RA   Jomaa H., Oldfield E.;
RT   "Crystallographic structures of two bisphosphonate:1-deoxyxylulose-5-
RT   phosphate reductoisomerase complexes.";
RL   J. Am. Chem. Soc. 126:10824-10825(2004).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH SUBSTRATE;
RP   FOSMIDOMYCIN AND NADP, AND SUBUNIT.
RX   PubMed=15567415; DOI=10.1016/j.jmb.2004.10.030;
RA   Mac Sweeney A., Lange R., Fernandes R.P., Schulz H., Dale G.E.,
RA   Douangamath A., Proteau P.J., Oefner C.;
RT   "The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate
RT   reductoisomerase in a ternary complex with the antimalarial compound
RT   fosmidomycin and NADPH reveals a tight-binding closed enzyme
RT   conformation.";
RL   J. Mol. Biol. 345:115-127(2005).
CC   -!- FUNCTION: Catalyzes the NADP-dependent rearrangement and reduction
CC       of 1-deoxy-D-xylulose-5-phosphate (DXP) to 2-C-methyl-D-erythritol
CC       4-phosphate (MEP).
CC   -!- CATALYTIC ACTIVITY: 2-C-methyl-D-erythritol 4-phosphate + NADP(+)
CC       = 1-deoxy-D-xylulose 5-phosphate + NADPH.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC       Note=Divalent cation. Prefers Mg(2+), Mn(2+) or Co(2+).;
CC   -!- ENZYME REGULATION: Inhibited by fosmidomycin.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=250 uM for DXP {ECO:0000269|PubMed:10787409};
CC         Note=Measured in the presence of manganese ions.;
CC       pH dependence:
CC         Optimum pH is 7.0-8.5. {ECO:0000269|PubMed:10787409};
CC       Temperature dependence:
CC         Optimum temperature is 40-60 degrees Celsius.
CC         {ECO:0000269|PubMed:10787409};
CC   -!- PATHWAY: Isoprenoid biosynthesis; isopentenyl diphosphate
CC       biosynthesis via DXP pathway; isopentenyl diphosphate from 1-
CC       deoxy-D-xylulose 5-phosphate: step 1/6.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11741911,
CC       ECO:0000269|PubMed:11872159, ECO:0000269|PubMed:12621040,
CC       ECO:0000269|PubMed:15339150, ECO:0000269|PubMed:15567415}.
CC   -!- SIMILARITY: Belongs to the DXR family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB013300; BAA32426.1; -; Genomic_DNA.
DR   EMBL; U70214; AAB08602.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73284.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA77848.2; -; Genomic_DNA.
DR   EMBL; D13334; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; E64741; E64741.
DR   RefSeq; NP_414715.1; NC_000913.3.
DR   RefSeq; WP_000811923.1; NZ_LN832404.1.
DR   PDB; 1JVS; X-ray; 2.20 A; A/B=2-398.
DR   PDB; 1K5H; X-ray; 2.50 A; A/B/C=1-398.
DR   PDB; 1ONN; X-ray; 2.60 A; A/B=1-398.
DR   PDB; 1ONO; X-ray; 2.50 A; A/B=1-398.
DR   PDB; 1ONP; X-ray; 2.50 A; A/B=1-398.
DR   PDB; 1Q0H; X-ray; 2.20 A; A=1-398.
DR   PDB; 1Q0L; X-ray; 2.65 A; A=1-398.
DR   PDB; 1Q0Q; X-ray; 1.90 A; A/B=1-398.
DR   PDB; 1T1R; X-ray; 2.30 A; A/B=2-398.
DR   PDB; 1T1S; X-ray; 2.40 A; A/B=2-398.
DR   PDB; 2EGH; X-ray; 2.20 A; A/B=2-398.
DR   PDB; 3ANL; X-ray; 2.10 A; A/B=2-398.
DR   PDB; 3ANM; X-ray; 2.00 A; A/B=2-398.
DR   PDB; 3ANN; X-ray; 2.00 A; A/B=2-398.
DR   PDB; 3R0I; X-ray; 2.10 A; A/B=1-398.
DR   PDBsum; 1JVS; -.
DR   PDBsum; 1K5H; -.
DR   PDBsum; 1ONN; -.
DR   PDBsum; 1ONO; -.
DR   PDBsum; 1ONP; -.
DR   PDBsum; 1Q0H; -.
DR   PDBsum; 1Q0L; -.
DR   PDBsum; 1Q0Q; -.
DR   PDBsum; 1T1R; -.
DR   PDBsum; 1T1S; -.
DR   PDBsum; 2EGH; -.
DR   PDBsum; 3ANL; -.
DR   PDBsum; 3ANM; -.
DR   PDBsum; 3ANN; -.
DR   PDBsum; 3R0I; -.
DR   ProteinModelPortal; P45568; -.
DR   SMR; P45568; -.
DR   BioGrid; 4259751; 202.
DR   DIP; DIP-9484N; -.
DR   IntAct; P45568; 6.
DR   STRING; 511145.b0173; -.
DR   BindingDB; P45568; -.
DR   ChEMBL; CHEMBL4091; -.
DR   DrugBank; DB02496; 1-Deoxy-D-xylulose 5-phosphate.
DR   DrugBank; DB04272; Citric Acid.
DR   DrugBank; DB02948; Fosmidomycin.
DR   PaxDb; P45568; -.
DR   PRIDE; P45568; -.
DR   EnsemblBacteria; AAC73284; AAC73284; b0173.
DR   EnsemblBacteria; BAA77848; BAA77848; BAA77848.
DR   GeneID; 945019; -.
DR   KEGG; ecj:JW0168; -.
DR   KEGG; eco:b0173; -.
DR   PATRIC; 32115455; VBIEscCol129921_0179.
DR   EchoBASE; EB2575; -.
DR   EcoGene; EG12715; dxr.
DR   eggNOG; ENOG4105CEA; Bacteria.
DR   eggNOG; COG0743; LUCA.
DR   HOGENOM; HOG000007221; -.
DR   InParanoid; P45568; -.
DR   KO; K00099; -.
DR   OMA; GFCPLSE; -.
DR   PhylomeDB; P45568; -.
DR   BioCyc; EcoCyc:DXPREDISOM-MONOMER; -.
DR   BioCyc; MetaCyc:DXPREDISOM-MONOMER; -.
DR   BRENDA; 1.1.1.267; 2026.
DR   SABIO-RK; P45568; -.
DR   UniPathway; UPA00056; UER00092.
DR   EvolutionaryTrace; P45568; -.
DR   PRO; PR:P45568; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0030604; F:1-deoxy-D-xylulose-5-phosphate reductoisomerase activity; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IDA:EcoCyc.
DR   GO; GO:0030145; F:manganese ion binding; IDA:EcoCyc.
DR   GO; GO:0070402; F:NADPH binding; IBA:GO_Central.
DR   GO; GO:0019288; P:isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway; IMP:EcoCyc.
DR   GO; GO:0051484; P:isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process; IBA:GO_Central.
DR   Gene3D; 3.40.50.720; -; 1.
DR   HAMAP; MF_00183; DXP_reductoisom; 1.
DR   InterPro; IPR003821; DXP_reductoisomerase.
DR   InterPro; IPR013644; DXP_reductoisomerase_C.
DR   InterPro; IPR013512; DXP_reductoisomerase_N.
DR   InterPro; IPR026877; DXPR_C.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   PANTHER; PTHR30525; PTHR30525; 1.
DR   Pfam; PF08436; DXP_redisom_C; 1.
DR   Pfam; PF02670; DXP_reductoisom; 1.
DR   Pfam; PF13288; DXPR_C; 1.
DR   PIRSF; PIRSF006205; Dxp_reductismrs; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF69055; SSF69055; 1.
DR   TIGRFAMs; TIGR00243; Dxr; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cobalt; Complete proteome; Isoprene biosynthesis;
KW   Magnesium; Manganese; Metal-binding; NADP; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN         1    398       1-deoxy-D-xylulose 5-phosphate
FT                                reductoisomerase.
FT                                /FTId=PRO_0000163651.
FT   NP_BIND       7     36       NADP. {ECO:0000269|PubMed:11872159,
FT                                ECO:0000269|PubMed:15567415}.
FT   REGION      222    228       Binding to substrate phosphate group.
FT   METAL       150    150       Divalent metal cation.
FT   METAL       152    152       Divalent metal cation.
FT   METAL       231    231       Divalent metal cation.
FT   BINDING     125    125       Substrate. {ECO:0000269|PubMed:15567415}.
FT   BINDING     152    152       Substrate. {ECO:0000269|PubMed:15567415}.
FT   BINDING     186    186       Substrate. {ECO:0000269|PubMed:15567415}.
FT   BINDING     209    209       Substrate. {ECO:0000269|PubMed:15567415}.
FT   BINDING     231    231       Substrate. {ECO:0000269|PubMed:15567415}.
FT   MUTAGEN      14     14       G->D: Loss of solubility and activity.
FT                                {ECO:0000269|PubMed:10787409}.
FT   MUTAGEN     153    153       H->Q: Increase in KM for substrate.
FT                                Reduces activity 35-fold.
FT                                {ECO:0000269|PubMed:10787409}.
FT   MUTAGEN     209    209       H->Q: Increase in KM for substrate.
FT                                Reduces activity 5000-fold.
FT                                {ECO:0000269|PubMed:10787409}.
FT   MUTAGEN     231    231       E->K: No effect on KM for substrate.
FT                                Reduces activity by over 99.9%.
FT                                {ECO:0000269|PubMed:10787409}.
FT   MUTAGEN     257    257       H->Q: Strong increase in KM for
FT                                substrate. Loss of activity.
FT                                {ECO:0000269|PubMed:10787409}.
FT   STRAND        2      8       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX        12     23       {ECO:0000244|PDB:1Q0Q}.
FT   TURN         25     27       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND       28     37       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX        39     49       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND       52     58       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX        59     71       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND       77     81       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX        82     89       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND       96     99       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       104    106       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       107    115       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND      119    122       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       125    131       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       133    142       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND      145    148       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       151    158       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       162    165       {ECO:0000244|PDB:1Q0Q}.
FT   TURN        166    170       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       174    176       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND      178    185       {ECO:0000244|PDB:1Q0Q}.
FT   TURN        189    192       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       195    200       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       203    207       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND      210    212       {ECO:0000244|PDB:1JVS}.
FT   HELIX       216    223       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       226    239       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       243    245       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND      246    250       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND      256    262       {ECO:0000244|PDB:1Q0Q}.
FT   STRAND      267    271       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       277    285       {ECO:0000244|PDB:1Q0Q}.
FT   TURN        299    301       {ECO:0000244|PDB:1Q0Q}.
FT   TURN        312    314       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       316    327       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       329    347       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       355    366       {ECO:0000244|PDB:1Q0Q}.
FT   HELIX       375    395       {ECO:0000244|PDB:1Q0Q}.
SQ   SEQUENCE   398 AA;  43388 MW;  8B532683A4FF1207 CRC64;
     MKQLTILGST GSIGCSTLDV VRHNPEHFRV VALVAGKNVT RMVEQCLEFS PRYAVMDDEA
     SAKLLKTMLQ QQGSRTEVLS GQQAACDMAA LEDVDQVMAA IVGAAGLLPT LAAIRAGKTI
     LLANKESLVT CGRLFMDAVK QSKAQLLPVD SEHNAIFQSL PQPIQHNLGY ADLEQNGVVS
     ILLTGSGGPF RETPLRDLAT MTPDQACRHP NWSMGRKISV DSATMMNKGL EYIEARWLFN
     ASASQMEVLI HPQSVIHSMV RYQDGSVLAQ LGEPDMRTPI AHTMAWPNRV NSGVKPLDFC
     KLSALTFAAP DYDRYPCLKL AMEAFEQGQA ATTALNAANE ITVAAFLAQQ IRFTDIAALN
     LSVLEKMDMR EPQCVDDVLS VDANAREVAR KEVMRLAS
//
